The labelled wake dose is 200 mg. Timing follows the shift.

About one hour before the shift, so around 21:00 if you start at 22:00. That is the labelled SWD instruction, not a forum average. Do not also take a morning 200 mg 'to stay normal on days off' unless a sleep physician wrote a different plan. The label is once daily. Food can delay the peak. A heavy meal at 20:30 then a tablet at 21:00 is a slower onset than the study clock. The wake plan markup is the short clock. If the roster flips to days, the clock must flip with it or you will be awake in the wrong half of the day.

Severe hepatic impairment: reduce to half the recommended dose. For a 200 mg labelled day that reads as 100 mg, which is a different tablet strength. Do not split a 200 mg in half unless the prescriber and the scored product allow a clean 100 mg. Geriatric patients may also start lower. The 200 mg lock is the usual adult with working liver enzymes.

The label wants alternative or added contraception during treatment and for one month after the last tablet. That includes depot and implants, not only the daily pill. CYP3A induction can lower ethinyl estradiol exposure. One month is the labelled tail, not a 'when you feel awake again' guess. If pregnancy is a near-term plan, say so before the first 200 mg. This desk will not pick a backup method for you. That is clinic counselling.

The OSA indication assumes CPAP is the treatment of the obstruction and has been used for an adequate period. Sleepiness is the target of modafinil, not the airway. Starting both the same week makes it impossible to know which intervention did what, and it skips the 'adequate period' idea. If residual sleepiness persists after documented CPAP use, 200 mg in the morning is the labelled adjunct. Recheck mask leak before blaming the tablet.

The label gives you morning for narcolepsy/OSA and one hour before the shift for SWD. A mixed roster is a sleep-medicine plan, not a single sentence on this sheet. Swallowing 200 mg at 21:00 Monday and 07:00 Thursday is two different clocks in one week. Insomnia on Friday is expected if you do that without a written scheme. Some people only take the tablet on night blocks and skip day blocks. That still needs the prescriber, because once-daily labelled use is not the same as an improvised on-off. The wake plan markup cannot invent a roster. Bring the actual shifts to clinic.

Stop unless the rash is clearly not the drug. The label is that blunt because you cannot tell a benign rash from SJS at the first spots. Pediatric programs saw serious rash around day 13 as a median. Adults have postmarketing SJS, TEN, and DRESS. Mouth sores, blistering, peeling, fever, or facial swelling are emergency territory. Restarting after a possible drug rash is a specialist call, not a 'try half a tablet' experiment.

No. Modafinil is not approved for pediatric ADHD. In that development program there were serious rashes, including a possible SJS case among hundreds of exposed children. Leftover adult 200 mg in a school bag is unlicensed use and a control-substance problem. This desk will not bless that. Return unused tablets to a pharmacy take-back.

Alcohol is a sedative. The tablet is trying to promote wake. Stacking them is how people get a false sense of fitness to drive home. The label does not give you a safe drink count. If the job includes a pour at dawn, the 200 mg is the wrong tool or the drink is. Psychiatric sides and rash still apply. A hangover plus residual modafinil is a messy morning.

Unlikely coincidence. Modafinil can induce CYP3A and lower cyclosporine. The label lists cyclosporine among substrates that may need a dose look. Do not guess a new cyclosporine milligram from this page. Check levels and call the transplant prescriber. If modafinil stops, levels can rebound. The CYP markup is the short arrow card.

Modafinil can raise blood pressure and heart rate a little. A new 158/94 is a reason to repeat the reading, list the caffeine, and call the prescriber - not a web 'it is fine'. People with prior stimulant-associated cardiac symptoms, LVH, or mitral-valve stories sit in labelled caution. Chest pain is a hold. Do not add a third antihypertensive at home to 'protect the 200 mg'. The wake tablet may be the wrong tool if the numbers stay high. Write sitting and standing values. Bring the CPAP adherence printout if the indication is OSA - untreated obstruction also moves BP.

The label allows doses up to 400 mg once daily and says they were tolerated. It also says there is no consistent evidence of extra benefit over 200 mg. Week one is early for a 'does nothing' verdict on a 15-hour half-life drug that reaches steady state in a few days - unless adherence, CPAP, or a wrong clock is the real problem. Check whether an OSA patient is actually using CPAP. Check whether a shift worker is taking the tablet an hour before work or at random. A rise to 400 mg is a prescriber decision, not a patient doubling. Severe hepatic impairment goes the other way: half dose.

Clock: morning versus one hour before the shift. CPAP reminder if the indication is OSA. Stop at rash. Backup contraception for the month after the last tablet. Schedule IV storage. Chest pain, mania, or swelling of the face is same-day care. Swiss emergency 144. Yvessa does not fill. Talk to the prescriber before changing the time or the milligrams. Disclaimer.